ID30441A - TREATMENT OF INFECTION CAUSED BY CHRONIC VIRUS GUM WITH M. VACCAE - Google Patents

TREATMENT OF INFECTION CAUSED BY CHRONIC VIRUS GUM WITH M. VACCAE

Info

Publication number
ID30441A
ID30441A IDW00200102000Q ID20010020Q ID30441A ID 30441 A ID30441 A ID 30441A ID W00200102000 Q IDW00200102000 Q ID W00200102000Q ID 20010020 Q ID20010020 Q ID 20010020Q ID 30441 A ID30441 A ID 30441A
Authority
ID
Indonesia
Prior art keywords
vaccae
gum
treatment
infection caused
chronic virus
Prior art date
Application number
IDW00200102000Q
Other languages
Indonesian (id)
Inventor
J L Stanford
G A W Rook
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Publication of ID30441A publication Critical patent/ID30441A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IDW00200102000Q 1999-02-16 2000-02-16 TREATMENT OF INFECTION CAUSED BY CHRONIC VIRUS GUM WITH M. VACCAE ID30441A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903539.6A GB9903539D0 (en) 1999-02-16 1999-02-16 Therapy using M.Vaccae

Publications (1)

Publication Number Publication Date
ID30441A true ID30441A (en) 2001-12-06

Family

ID=10847890

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200102000Q ID30441A (en) 1999-02-16 2000-02-16 TREATMENT OF INFECTION CAUSED BY CHRONIC VIRUS GUM WITH M. VACCAE

Country Status (26)

Country Link
US (1) US6596282B1 (en)
EP (1) EP1152768B1 (en)
JP (1) JP2002537266A (en)
KR (1) KR20010113691A (en)
CN (1) CN1377274A (en)
AP (1) AP2001002254A0 (en)
AT (1) ATE246930T1 (en)
AU (1) AU766113B2 (en)
BR (1) BR0008269A (en)
CA (1) CA2361925A1 (en)
DE (1) DE60004481T2 (en)
DK (1) DK1152768T3 (en)
ES (1) ES2204508T3 (en)
GB (1) GB9903539D0 (en)
HK (1) HK1038697B (en)
HU (1) HUP0105474A3 (en)
ID (1) ID30441A (en)
MX (1) MXPA01008243A (en)
NO (1) NO20013939L (en)
NZ (1) NZ513320A (en)
PL (1) PL350577A1 (en)
PT (1) PT1152768E (en)
RU (1) RU2001125429A (en)
TR (1) TR200102388T2 (en)
WO (1) WO2000048615A2 (en)
ZA (1) ZA200106248B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
CN111281893B (en) * 2020-03-02 2021-11-19 广西医科大学第一附属医院 Application of mycobacterium vaccae for injection in preparation of medicament for preventing and treating COVID-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
ATE154759T1 (en) 1990-11-08 1997-07-15 Univ London MYCOBACTERIUM AS AN ADJUVANT FOR ANTIGENS
CA2315539A1 (en) 1997-12-23 1999-07-01 Genesis Research & Development Corporation Limited Compositions derived from mycobacterium vaccae and methods for their use

Also Published As

Publication number Publication date
TR200102388T2 (en) 2002-10-21
MXPA01008243A (en) 2002-08-30
BR0008269A (en) 2001-11-06
DE60004481T2 (en) 2004-06-24
EP1152768B1 (en) 2003-08-13
GB9903539D0 (en) 1999-04-07
PL350577A1 (en) 2002-12-30
DE60004481D1 (en) 2003-09-18
NO20013939D0 (en) 2001-08-14
AU766113B2 (en) 2003-10-09
ES2204508T3 (en) 2004-05-01
WO2000048615A2 (en) 2000-08-24
AU2561100A (en) 2000-09-04
AP2001002254A0 (en) 2001-09-30
NO20013939L (en) 2001-10-04
ATE246930T1 (en) 2003-08-15
HK1038697A1 (en) 2002-03-28
PT1152768E (en) 2003-12-31
US6596282B1 (en) 2003-07-22
RU2001125429A (en) 2003-06-10
CA2361925A1 (en) 2000-08-24
HUP0105474A3 (en) 2003-11-28
KR20010113691A (en) 2001-12-28
NZ513320A (en) 2004-04-30
ZA200106248B (en) 2002-01-23
HUP0105474A2 (en) 2002-05-29
EP1152768A2 (en) 2001-11-14
DK1152768T3 (en) 2003-11-24
HK1038697B (en) 2004-03-19
WO2000048615A3 (en) 2000-12-14
JP2002537266A (en) 2002-11-05
CN1377274A (en) 2002-10-30

Similar Documents

Publication Publication Date Title
DK1196172T3 (en) (S, S) reboxetine for the treatment of chronic pain
DK1410805T3 (en) Vaccine against HPV
DK1335678T3 (en) Oral treatment system
BR0014930B1 (en) cannula.
DK1183269T3 (en) Attenuated microorganisms for the treatment of infection
NO20052580D0 (en) Compounds for the treatment of infection by Flavivirida viruses
DE60001421D1 (en) EXHAUST TREATMENT
EP1469812A4 (en) ORAL INSULIN THERAPY
FI20000863A0 (en) New treatment procedure
NO20032122D0 (en) Improved treatment
DE60021065D1 (en) VIRUS TREATMENT
DE60032884D1 (en) BLOOD TREATMENT SYSTEM
DE60220220D1 (en) Blood treatment system
NO20043445L (en) Combination therapy for the treatment of bacterial infections
ID30441A (en) TREATMENT OF INFECTION CAUSED BY CHRONIC VIRUS GUM WITH M. VACCAE
NO20013596D0 (en) Sludge treatment
DE60011060D1 (en) VIRUS TREATMENT
IT1310385B1 (en) DEVICE TO IMPROVE BREATHING.
NO20022949D0 (en) Attenuated microorganisms for the treatment of infection
DK1180041T4 (en) Vaccine against ISA virus
MA26931A1 (en) CRYSTALLINE THERAPEUTIC AGENT.
ZA200400508B (en) The treatment of virally caused topical infections.
IT248695Y1 (en) MOTORIZED MASSAGER.
RU2003135700A (en) METHOD FOR TREATING SURGICAL INFECTION
ITFR20020012A1 (en) REMEDY TO HEAL INFECTED WOUNDS, REMOVE BURNING AND RESTORE THE SKIN